$UUUU
ENERGY FUELS INC Stock $uuuu

$uuuu Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000138584924000029 Filed on May 03, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$8.719M	$25.43M
YoY Change	27.04%	29.64%
Cost Of Revenue	$3.681M	$11.05M
YoY Change	-15.71%	33.7%
Gross Profit	$5.038M	$14.37M
YoY Change	101.84%	26.68%
Gross Profit Margin	57.78%	56.53%
Selling, General & Admin	$7.083M	$7.939M
YoY Change	-5.03%	31.81%
% of Gross Profit	140.59%	55.23%
Research & Development	$1.867M	$2.135M
YoY Change	-51.13%	-31.13%
% of Gross Profit	37.06%	14.85%
Depreciation & Amortization	$620.0K	$670.0K
YoY Change	-6.06%	1.52%
% of Gross Profit	12.31%	4.66%
Operating Expenses	$7.083M	$7.939M
YoY Change	-5.03%	31.81%
Operating Profit	-$9.044M	$2.021M
YoY Change	-15.18%	-599.01%
Interest Expense	$2.623M	$1.617M
YoY Change	-13.15%	-202.34%
% of Operating Profit		80.01%
Other Income/Expense, Net	$2.625M	$1.617M
YoY Change	-54.57%	-98.59%
Pretax Income	-$6.419M	$3.638M
YoY Change	31.27%	-96.82%
Income Tax	$0.00
% Of Pretax Income
Net Earnings	-$6.420M	$3.640M
YoY Change	31.42%	-96.81%
Net Earnings / Revenue	-73.63%	14.32%
Basic Earnings Per Share	-$0.04	$0.02
Diluted Earnings Per Share	-$0.04	$0.02
COMMON SHARES
Basic Shares Outstanding	163.7M shares	163.6M shares
Diluted Shares Outstanding	163.7M shares	164.6M shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$171.2M	$195.6M
YoY Change	71.76%	87.51%
Cash & Equivalents	$24.59M	$54.78M
Short-Term Investments	$146.7M	$140.8M
Other Short-Term Assets	$3.985M	$3.394M
YoY Change	-7.33%	-24.58%
Inventory	$30.41M	$32.07M
Prepaid Expenses	$3.985M	$3.394M
Receivables	$9.021M	$361.0K
Other Receivables	$527.0K	$493.0K
Total Short-Term Assets	$208.3M	$228.1M
YoY Change	48.86%	53.15%
LONG-TERM ASSETS
Property, Plant & Equipment	$40.36M	$29.80M
YoY Change	131.57%	103.61%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$3.473M	$1.297M
YoY Change	-80.04%	-92.09%
Other Assets	$24.81M	$21.54M
YoY Change	26.59%	9.91%
Total Long-Term Assets	$195.1M	$177.7M
YoY Change	-15.96%	-21.55%
TOTAL ASSETS
Total Short-Term Assets	$208.3M	$228.1M
Total Long-Term Assets	$195.1M	$177.7M
Total Assets	$403.4M	$405.8M
YoY Change	8.42%	8.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.246M	$1.389M
YoY Change	41.7%	8.94%
Accrued Expenses	$5.119M	$4.137M
YoY Change	27.98%	3.42%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$7.365M	$5.526M
YoY Change	32.25%	4.21%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$13.29M	$12.57M
YoY Change	16.61%	13.25%
Total Long-Term Liabilities	$13.29M	$12.57M
YoY Change	16.61%	13.25%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.365M	$5.526M
Total Long-Term Liabilities	$13.29M	$12.57M
Total Liabilities	$20.66M	$18.10M
YoY Change	22.03%	10.09%
SHAREHOLDERS EQUITY
Retained Earnings	-$359.0M	-$352.6M
YoY Change	3.55%	3.15%
Common Stock	$739.8M	$738.3M
YoY Change	5.7%	5.65%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$378.8M	$383.7M
YoY Change
Total Liabilities & Shareholders Equity	$403.4M	$405.8M
YoY Change	8.42%	8.08%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	-$6.420M	$3.640M
YoY Change	31.42%	-96.81%
Depreciation, Depletion And Amortization	$620.0K	$670.0K
YoY Change	-6.06%	1.52%
Cash From Operating Activities	-$9.675M	$8.841M
YoY Change	601.09%	-442.81%
INVESTING ACTIVITIES
Capital Expenditures	$13.79M	$7.259M
YoY Change	127.48%	-70.78%
Acquisitions
YoY Change
Other Investing Activities	-$6.346M	-$7.565M
YoY Change	1713.14%	-229.54%
Cash From Investing Activities	-$20.13M	-$14.82M
YoY Change	214.06%	-21.99%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	53.00K	$3.502M
YoY Change	-110.0%	-513.95%
NET CHANGE
Cash From Operating Activities	-9.675M	$8.841M
Cash From Investing Activities	-20.13M	-$14.82M
Cash From Financing Activities	53.00K	$3.502M
Net Change In Cash	-29.75M	-$2.527M
YoY Change	257.61%	-86.65%
FREE CASH FLOW
Cash From Operating Activities	-$9.675M	$8.841M
Capital Expenditures	$13.79M	$7.259M
Free Cash Flow	-$23.46M	$1.582M
YoY Change	215.32%	-105.77%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	efr	Revenues Vanadium Concentrates RevenuesVanadiumConcentrates	0	usd
CY2023Q1	efr	Revenues Vanadium Concentrates RevenuesVanadiumConcentrates	871000	usd
CY2024Q1	efr	Revenues Alternate Feed Materials Processing And Other RevenuesAlternateFeedMaterialsProcessingAndOther	112000	usd
CY2023Q1	efr	Revenues Alternate Feed Materials Processing And Other RevenuesAlternateFeedMaterialsProcessingAndOther	272000	usd
CY2024Q1	us-gaap	Revenues Revenues	25426000	usd
CY2023Q1	us-gaap	Revenues Revenues	19613000	usd
CY2024Q1	efr	Costof Revenue Uranium Concentrates CostofRevenueUraniumConcentrates	11052000	usd
CY2023Q1	efr	Costof Revenue Uranium Concentrates CostofRevenueUraniumConcentrates	7715000	usd
CY2024Q1	efr	Cost Of Revenue Vanadium Concentrates CostOfRevenueVanadiumConcentrates	0	usd
CY2023Q1	efr	Cost Of Revenue Vanadium Concentrates CostOfRevenueVanadiumConcentrates	551000	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	11052000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	8266000	usd
CY2024Q1	efr	Exploration Development Permitting And Land Holding ExplorationDevelopmentPermittingAndLandHolding	2805000	usd
CY2023Q1	efr	Exploration Development Permitting And Land Holding ExplorationDevelopmentPermittingAndLandHolding	3096000	usd
CY2024Q1	efr	Standby Costs StandbyCosts	1333000	usd
CY2023Q1	efr	Standby Costs StandbyCosts	2287000	usd
CY2024Q1	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	276000	usd
CY2023Q1	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	346000	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7939000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6023000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	2021000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-405000	usd
CY2024Q1	efr	Gain On Disposal Of Non Core Assets GainOnDisposalOfNonCoreAssets	0	usd
CY2023Q1	efr	Gain On Disposal Of Non Core Assets GainOnDisposalOfNonCoreAssets	116450000	usd
CY2024Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	1617000	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1781000	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1617000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	114669000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	3638000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	114264000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.72
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.72
CY2024Q1	us-gaap	Profit Loss ProfitLoss	3639000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	114265000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	3638000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	114264000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	54780000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	57445000	usd
CY2024Q1	efr	Marketable Securities Debt And Equity Fvni MarketableSecuritiesDebtAndEquityFVNI	140796000	usd
CY2023Q4	efr	Marketable Securities Debt And Equity Fvni MarketableSecuritiesDebtAndEquityFVNI	133044000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	223000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	223000	usd
CY2024Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	854000	usd
CY2023Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	816000	usd
CY2024Q1	efr	Inventory Current InventoryCurrent	28245000	usd
CY2023Q4	efr	Inventory Current InventoryCurrent	38868000	usd
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3394000	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2522000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	228069000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	232695000	usd
CY2024Q1	us-gaap	Mineral Properties Net MineralPropertiesNet	122406000	usd
CY2023Q4	us-gaap	Mineral Properties Net MineralPropertiesNet	119581000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	29799000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	26123000	usd
CY2024Q1	us-gaap	Inventory Noncurrent InventoryNoncurrent	3826000	usd
CY2023Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	1852000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1174000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1219000	usd
CY2024Q1	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	1297000	usd
CY2023Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	1356000	usd
CY2024Q1	us-gaap	Nontrade Receivables Noncurrent NontradeReceivablesNoncurrent	1499000	usd
CY2023Q4	us-gaap	Nontrade Receivables Noncurrent NontradeReceivablesNoncurrent	1534000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	17717000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	17579000	usd
CY2024Q1	us-gaap	Assets Assets	405787000	usd
CY2023Q4	us-gaap	Assets Assets	401939000	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	5317000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	10161000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	209000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	199000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	5526000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10360000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1064000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1120000	usd
CY2024Q1	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	11175000	usd
CY2023Q4	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	10922000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	332000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	332000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	18097000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	22734000	usd
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	163651897	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	163651897	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	162659155	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	162659155	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	738297000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	733450000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-352619000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-356258000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1946000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1946000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	383732000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	375246000	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	3958000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	3959000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	387690000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	379205000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	405787000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	401939000	usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	379205000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	3638000	usd
CY2024Q1	efr	Shares Issued For Cash By At The Market Offering SharesIssuedForCashByAtTheMarketOffering	4898000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	110000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1345000	usd
CY2024Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	552000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	103000	usd
CY2024Q1	efr	Stock Issued During Period Value Cash Paymentfor Tax Withholding StockIssuedDuringPeriodValueCashPaymentforTaxWithholding	837000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	387690000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	244409000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	114264000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1186000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	72000	usd
CY2023Q1	efr	Stock Issued During Period Value Cash Paymentfor Tax Withholding StockIssuedDuringPeriodValueCashPaymentforTaxWithholding	918000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	359013000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	3638000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	114264000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	668000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	655000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1345000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1186000	usd
CY2024Q1	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	276000	usd
CY2023Q1	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	346000	usd
CY2024Q1	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-702000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	24000	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	0	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-2959000	usd
CY2024Q1	efr	Debt Securities Fvni Gain Loss DebtSecuritiesFVNIGainLoss	212000	usd
CY2023Q1	efr	Debt Securities Fvni Gain Loss DebtSecuritiesFVNIGainLoss	0	usd
CY2024Q1	efr	Gain On Disposal Of Non Core Assets GainOnDisposalOfNonCoreAssets	0	usd
CY2023Q1	efr	Gain On Disposal Of Non Core Assets GainOnDisposalOfNonCoreAssets	116450000	usd
CY2024Q1	efr	Miscellaneous Non Cash Income Expenses MiscellaneousNonCashIncomeExpenses	-24000	usd
CY2023Q1	efr	Miscellaneous Non Cash Income Expenses MiscellaneousNonCashIncomeExpenses	149000	usd
CY2024Q1	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	540000	usd
CY2023Q1	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	325000	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-8719000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-538000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	60000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	1540000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	850000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	1233000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-4821000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-3104000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	8841000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2579000	usd
CY2024Q1	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	4783000	usd
CY2023Q1	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	2042000	usd
CY2024Q1	efr	Purchase Of Mineral Properties PurchaseOfMineralProperties	2476000	usd
CY2023Q1	efr	Purchase Of Mineral Properties PurchaseOfMineralProperties	1171000	usd
CY2024Q1	efr	Acquisition Of Mineral Properties AcquisitionOfMineralProperties	0	usd
CY2023Q1	efr	Acquisition Of Mineral Properties AcquisitionOfMineralProperties	21624000	usd
CY2024Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	64730000	usd
CY2023Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	47924000	usd
CY2024Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	57165000	usd
CY2023Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	53759000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-14824000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-19002000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4788000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2024Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	103000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	72000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3502000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-846000	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-46000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	22000	usd
CY2024Q1	efr	Release Of Restricted Cash ReleaseOfRestrictedCash	0	usd
CY2023Q1	efr	Release Of Restricted Cash ReleaseOfRestrictedCash	-3475000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2527000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-18930000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	75024000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	80269000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	72497000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	61339000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	65000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	11000	usd
CY2024Q1	efr	Increase Decrease In Accrued Capital Expenditures And Accounts Payable For Property Plant And Equipment IncreaseDecreaseInAccruedCapitalExpendituresAndAccountsPayableForPropertyPlantAndEquipment	-18000	usd
CY2023Q1	efr	Increase Decrease In Accrued Capital Expenditures And Accounts Payable For Property Plant And Equipment IncreaseDecreaseInAccruedCapitalExpendituresAndAccountsPayableForPropertyPlantAndEquipment	1456000	usd
CY2024Q1	efr	Noncash Acquisition Of Convertible Note NoncashAcquisitionOfConvertibleNote	0	usd
CY2023Q1	efr	Noncash Acquisition Of Convertible Note NoncashAcquisitionOfConvertibleNote	59259000	usd
CY2024Q1	us-gaap	Equity Securities Fv Ni Cost EquitySecuritiesFvNiCost	28159000	usd
CY2024Q1	efr	Equity Securities Fvni Gross Unrealized Loss EquitySecuritiesFVNIGrossUnrealizedLoss	3034000	usd
CY2024Q1	efr	Equity Securities Fvni Gross Unrealized Gain EquitySecuritiesFVNIGrossUnrealizedGain	0	usd
CY2024Q1	us-gaap	Equity Securities Fv Ni Current And Noncurrent EquitySecuritiesFvNiCurrentAndNoncurrent	25125000	usd
CY2024Q1	efr	Debt Securities Available For Sale Held To Maturity And Equity Securities Fvni Cost DebtSecuritiesAvailableForSaleHeldToMaturityAndEquitySecuritiesFVNICost	142727000	usd
CY2024Q1	efr	Debt Securities Available For Sale Held To Maturity And Equity Securities Fvni Accumulated Gross Unrealized Loss Before Tax DebtSecuritiesAvailableForSaleHeldToMaturityAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax	3034000	usd
CY2024Q1	efr	Total Marketable Securities TotalMarketableSecurities	1103000	usd
CY2024Q1	efr	Debt Securities Available For Sale Held To Maturity And Equity Securities Fvni DebtSecuritiesAvailableForSaleHeldToMaturityAndEquitySecuritiesFVNI	140796000	usd
CY2023Q4	efr	Debt Securities Fvni Cost DebtSecuritiesFVNICost	106791000	usd
CY2023Q4	efr	Debt Securities Fvni Gross Unrealized Loss DebtSecuritiesFVNIGrossUnrealizedLoss	0	usd
CY2023Q4	efr	Debt Securities Fvni Gross Unrealized Gain DebtSecuritiesFVNIGrossUnrealizedGain	675000	usd
CY2023Q4	efr	Debt Securities Fvni DebtSecuritiesFVNI	107466000	usd
CY2023Q4	us-gaap	Equity Securities Fv Ni Cost EquitySecuritiesFvNiCost	28159000	usd
CY2023Q4	efr	Equity Securities Fvni Gross Unrealized Loss EquitySecuritiesFVNIGrossUnrealizedLoss	2581000	usd
CY2023Q4	efr	Equity Securities Fvni Gross Unrealized Gain EquitySecuritiesFVNIGrossUnrealizedGain	0	usd
CY2023Q4	us-gaap	Equity Securities Fv Ni Current And Noncurrent EquitySecuritiesFvNiCurrentAndNoncurrent	25578000	usd
CY2023Q4	efr	Debt Securities Available For Sale Held To Maturity And Equity Securities Fvni Cost DebtSecuritiesAvailableForSaleHeldToMaturityAndEquitySecuritiesFVNICost	134950000	usd
CY2023Q4	efr	Debt Securities Available For Sale Held To Maturity And Equity Securities Fvni Accumulated Gross Unrealized Loss Before Tax DebtSecuritiesAvailableForSaleHeldToMaturityAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax	2581000	usd
CY2023Q4	efr	Total Marketable Securities TotalMarketableSecurities	675000	usd
CY2023Q4	efr	Debt Securities Available For Sale Held To Maturity And Equity Securities Fvni DebtSecuritiesAvailableForSaleHeldToMaturityAndEquitySecuritiesFVNI	133044000	usd
CY2024Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	25006000	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	35807000	usd
CY2024Q1	efr	Inventory Of Ore In Stockpiles InventoryOfOreInStockpiles	5418000	usd
CY2023Q4	efr	Inventory Of Ore In Stockpiles InventoryOfOreInStockpiles	3072000	usd
CY2024Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	1647000	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1841000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	32071000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	40720000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	66690000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	62048000	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	36891000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	35925000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	29799000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	26123000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	670000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	660000	usd
CY2024Q1	us-gaap	Mineral Properties Net MineralPropertiesNet	122406000	usd
CY2023Q4	us-gaap	Mineral Properties Net MineralPropertiesNet	119581000	usd
CY2023Q1	efr	Number Of Purchase Agreements NumberOfPurchaseAgreements	2	purchaseagreement
CY2023Q1	efr	Number Of Mineral Concessions Acquired NumberOfMineralConcessionsAcquired	17	mineral_concession
CY2023Q1	efr	Purchase Agreement Acres To Purchase PurchaseAgreementAcresToPurchase	37300	acre
CY2023Q1	efr	Purchase Agreement Miles To Purchase PurchaseAgreementMilesToPurchase	58.3	mi
CY2023Q1	efr	Number Of Mineral Concessions Acquired NumberOfMineralConcessionsAcquired	17	mineral_concession
CY2023Q1	efr	Purchase Agreement Purchase Price PurchaseAgreementPurchasePrice	27500000	usd
CY2023Q1	efr	Purchase Agreement Deposit Payment PurchaseAgreementDepositPayment	5900000	usd
CY2023Q1	efr	Purchase Agreement Payment Due At Closing PurchaseAgreementPaymentDueAtClosing	21600000	usd
CY2023Q1	efr	Purchase Agreement Direct Deal Costs PurchaseAgreementDirectDealCosts	1630000	usd
CY2023	efr	Restricted Cash And Cash Equivalents Held For Sale RestrictedCashAndCashEquivalentsHeldForSale	3590000	usd
CY2023	efr	Restricted Cash And Cash Equivalents Held For Sale RestrictedCashAndCashEquivalentsHeldForSale	3590000	usd
CY2023Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	10922000	usd
CY2024Q1	us-gaap	Asset Retirement Obligation Revision Of Estimate AssetRetirementObligationRevisionOfEstimate	23000	usd
CY2024Q1	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	276000	usd
CY2024Q1	us-gaap	Asset Retirement Obligation AssetRetirementObligation	11175000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	17579000	usd
CY2024Q1	efr	Additional Collateral Posted AdditionalCollateralPosted	138000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	17717000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3639000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	114265000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	163414293	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	157930097	shares
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1218484	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1298970	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	164632777	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	159229067	shares
CY2024Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.02
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.72
CY2024Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.02
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.72
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	300000	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	260000	shares
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1345000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1186000	usd
CY2024Q1	efr	Sharebased Compensation Arrangementby Sharebased Payment Award Options Exercisable Period SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisablePeriod	P5Y
CY2024Q1	us-gaap	Share Price SharePrice	7.48
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	523468	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.48
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	561729	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	7.81
CY2024Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	29116	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	3.53
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	5513	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	7.45
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	415	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	2.92
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1050153	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.27
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y4M17D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	1014000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	414565	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.02
CY2024Q1	efr	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term Instant SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermInstant	P1Y10M2D
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	1009000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	3640000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	114260000	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2024Q1	efr	Change In Value Of Investments Accounted At Fair Value ChangeInValueOfInvestmentsAccountedAtFairValue	0	usd
CY2023Q1	efr	Change In Value Of Investments Accounted At Fair Value ChangeInValueOfInvestmentsAccountedAtFairValue	-2959000	usd
CY2024Q1	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	540000	usd
CY2023Q1	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	325000	usd
CY2024Q1	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	212000	usd
CY2023Q1	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	0	usd
CY2024Q1	efr	Debt Securities Convertible Note Unrealized Gain Loss DebtSecuritiesConvertibleNoteUnrealizedGainLoss	0	usd
CY2023Q1	efr	Debt Securities Convertible Note Unrealized Gain Loss DebtSecuritiesConvertibleNoteUnrealizedGainLoss	-198000	usd
CY2024Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-702000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	26000	usd
CY2024Q1	efr	Component Of Other Income Expense ComponentOfOtherIncomeExpense	1567000	usd
CY2023Q1	efr	Component Of Other Income Expense ComponentOfOtherIncomeExpense	1025000	usd
CY2024Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	1617000	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1781000	usd
CY2024Q1	us-gaap	Accounts Receivable Gross AccountsReceivableGross	361000	usd
CY2023Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	406000	usd
CY2024Q1	us-gaap	Financing Receivable Accrued Interest After Allowance For Credit Loss FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss	343000	usd
CY2023Q4	us-gaap	Financing Receivable Accrued Interest After Allowance For Credit Loss FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss	343000	usd
CY2024Q1	efr	Accounts And Other Receivables Net AccountsAndOtherReceivablesNet	150000	usd
CY2023Q4	efr	Accounts And Other Receivables Net AccountsAndOtherReceivablesNet	67000	usd
CY2024Q1	efr	Receivables Net ReceivablesNet	854000	usd
CY2023Q4	efr	Receivables Net ReceivablesNet	816000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1389000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1006000	usd
CY2024Q1	efr	Accrued Operating Expenses Current AccruedOperatingExpensesCurrent	1614000	usd
CY2023Q4	efr	Accrued Operating Expenses Current AccruedOperatingExpensesCurrent	4391000	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1714000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4162000	usd
CY2024Q1	efr	Accrued Capital Expenditures Current AccruedCapitalExpendituresCurrent	406000	usd
CY2023Q4	efr	Accrued Capital Expenditures Current AccruedCapitalExpendituresCurrent	205000	usd
CY2024Q1	efr	Accrued Property Taxes Current AccruedPropertyTaxesCurrent	188000	usd
CY2023Q4	efr	Accrued Property Taxes Current AccruedPropertyTaxesCurrent	393000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	6000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	4000	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	5317000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	10161000	usd
CY2023Q4	efr	Convertible Note Receivable Redeemed ConvertibleNoteReceivableRedeemed	40000000	usd
CY2023Q4	efr	Convertible Notes Receivable Sold ConvertibleNotesReceivableSold	20000000	usd
CY2023Q4	efr	Convertible Note Receivable Consideration Received ConvertibleNoteReceivableConsiderationReceived	21000000	usd
CY2023Q4	efr	Convertible Note Receivable Unpaid Accrued Interest ConvertibleNoteReceivableUnpaidAccruedInterest	1500000	usd
CY2023Q4	efr	Convertible Note Receivable Sales Commission ConvertibleNoteReceivableSalesCommission	100000	usd
CY2023Q4	efr	Proceeds From Convertible Note Receivable ProceedsFromConvertibleNoteReceivable	22400000	usd
CY2024Q1	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	178761000	usd
CY2023Q4	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	173556000	usd
CY2023Q1	efr	Change In Value Of Investments Accounted At Fair Value ChangeInValueOfInvestmentsAccountedAtFairValue	-2960000	usd
CY2024Q1	us-gaap	Accounts Receivable Gross AccountsReceivableGross	360000	usd
CY2023Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	410000	usd
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001385849-24-000029-index-headers.html	Edgar Link	pending
0001385849-24-000029-index.html	Edgar Link	pending
0001385849-24-000029.txt	Edgar Link	pending
0001385849-24-000029-xbrl.zip	Edgar Link	pending
efr-20240331.htm	Edgar Link	pending
efr-20240331.xsd	Edgar Link	pending
efr-20240331_g1.jpg	Edgar Link	pending
efr03312024-exx231.htm	Edgar Link	pending
efr03312024-exx311.htm	Edgar Link	pending
efr03312024-exx312.htm	Edgar Link	pending
efr03312024-exx321.htm	Edgar Link	pending
efr03312024-exx322.htm	Edgar Link	pending
efr03312024-exx951.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
efr-20240331_cal.xml	Edgar Link	unprocessable
efr-20240331_def.xml	Edgar Link	unprocessable
efr-20240331_lab.xml	Edgar Link	unprocessable
efr-20240331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
efr-20240331_htm.xml	Edgar Link	completed
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$UUUU
ENERGY FUELS INC Stock $uuuu

2024 Q2 Form 10-Q Financial Statement

#000138584924000029 Filed on May 03, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$UUUU ENERGY FUELS INC Stock $uuuu

2024 Q2 Form 10-Q Financial Statement

#000138584924000029 Filed on May 03, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$UUUU
ENERGY FUELS INC Stock $uuuu